Latest News about COVID/19 Vaccine
Recent news which mentions COVID/19 Vaccine
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
From Benzinga
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
January 24, 2022
From Benzinga
Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses
January 24, 2022
From Benzinga
From Benzinga
Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters
January 20, 2022
From Benzinga
Three doses of Valneva's COVID-19 Vaccine Neutralizes Omicron Variant, Lab Study Shows
January 19, 2022
From Benzinga
From Benzinga
Johnson and Johnson' COVID-19 Booster Is 85% Effective Against Omicron Hospitalization, South African Study Shows
January 14, 2022
Tickers
JNJ
From Benzinga
AstraZeneca's COVID-19 Vaccine Booster Against Omicron, Delta - New Data Supports Use
January 13, 2022
From Benzinga
WHO's Technical Body Says Updated COVID-19 Vaccines Needed To Combat Omicron: Reuters
January 12, 2022
From Benzinga
From Benzinga
Ocugen-Bharat Biotech Partnered COVID-19 Booster Covaxin Neutralizes Omicron, Delta Variants
January 12, 2022
Tickers
OCGN
From Benzinga
Moderna COVID-19 Shot Lowers Risk Of Infection, Hospitalization Compared To Pfizer's, VA Real-World Data Shows
January 11, 2022
From Benzinga
From Benzinga
CureVac Outlines Upcoming Catalysts For Vaccine Programs
January 10, 2022
From Benzinga
Tonix Pharma, Kansas University Join Forces To Work On Next-Gen mRNA-Based COVID-19 Vaccine
January 04, 2022
From Benzinga
From Benzinga
From Benzinga
FDA Approves Pfizer's COVID-19 Booster For Age 12 To 15
January 03, 2022
From Benzinga
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
January 03, 2022
From Benzinga
FedEx Marks Anniversary of First COVID-19 Vaccine Deliveries
December 28, 2021
Tickers
FDX
From Benzinga
From Benzinga
Novavax Initiates Phase 3 COVID-19 Vaccine Booster Study
December 22, 2021
Tickers
NVAX
From Benzinga
Novavax's COVID-19 Vaccine Scores Conditional Approval In Europe
December 20, 2021
Tickers
NVAX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.